DK0723444T3 - Levobupivacain, som er egnet til behandling af kronisk smerte - Google Patents

Levobupivacain, som er egnet til behandling af kronisk smerte

Info

Publication number: DK0723444T3
Authority: DK; Denmark
Prior art keywords: levobupivacaine; pct; treatment; chronic pain; sec
Prior art date: 1993-10-13

Application number

DK94929595.0T

Other languages

English (en)

Inventor

Hazel Judith Bardsley

Laurence Mather

Original Assignee

Chiroscience Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-10-13

Filing date

1994-10-13

Publication date

1997-12-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10743430&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0723444(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1994-10-13 Application filed by Chiroscience Ltd filed Critical Chiroscience Ltd

1997-12-29 Application granted granted Critical

1997-12-29 Publication of DK0723444T3 publication Critical patent/DK0723444T3/da

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Pain & Pain Management (AREA)
Neurology (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Engineering & Computer Science (AREA)
Neurosurgery (AREA)
Rheumatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Hydrogenated Pyridines (AREA)
Other In-Based Heterocyclic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Steroid Compounds (AREA)

DK94929595.0T 1993-10-13 1994-10-13 Levobupivacain, som er egnet til behandling af kronisk smerte DK0723444T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB939321061A GB9321061D0 (en)	1993-10-13	1993-10-13	Analgestic agent and its use

Publications (1)

Publication Number	Publication Date
DK0723444T3 true DK0723444T3 (da)	1997-12-29

Family

ID=10743430

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK94929595.0T DK0723444T3 (da)	1993-10-13	1994-10-13	Levobupivacain, som er egnet til behandling af kronisk smerte

Country Status (16)

Country	Link
US (1)	US5955479A (da)
EP (1)	EP0723444B1 (da)
JP (1)	JPH09503777A (da)
KR (1)	KR100343314B1 (da)
CN (1)	CN1074919C (da)
AT (1)	ATE154758T1 (da)
AU (1)	AU692477B2 (da)
CA (1)	CA2173208C (da)
DE (1)	DE69403969T2 (da)
DK (1)	DK0723444T3 (da)
ES (1)	ES2105766T3 (da)
GB (1)	GB9321061D0 (da)
GR (1)	GR3024787T3 (da)
HK (1)	HK1006421A1 (da)
NO (1)	NO309304B1 (da)
WO (1)	WO1995010276A1 (da)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE69628743T2 (de) *	1995-04-13	2004-05-13	Darwin Discovery Ltd., Slough	Levobupivacain und dessen verwendung als anästhetikum bei schwangeren frauen
GB9704370D0 (en) *	1997-03-03	1997-04-23	Chiroscience Ltd	Levobupivacaine and its use
GB9704349D0 (en) *	1997-03-03	1997-04-23	Chiroscience Ltd	Levobupivacaine and its use
GB9704352D0 (en) *	1997-03-03	1997-04-23	Chiroscience Ltd	Levobupivacaine and its use
JP4521117B2 (ja) *	1997-07-21	2010-08-11	ブルース・エイチ・レヴィン	偏頭痛、群発性頭痛、緊張性頭痛、血管疾患に伴う頭痛、耳鳴りまたは筋肉性頭痛を治療するための医薬
US7799337B2 (en)	1997-07-21	2010-09-21	Levin Bruce H	Method for directed intranasal administration of a composition
US6432986B2 (en)	1997-07-21	2002-08-13	Bruce H. Levin	Compositions, kits, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
DE69814394T2 (de) *	1997-07-22	2004-03-11	Darwin Discovery Ltd., Slough	Verwendung von levobupivacain
EP2198854B1 (en)	1997-09-18	2011-11-30	Pacira Pharmaceuticals, Inc.	Sustained-release liposomal anesthetic compositions
ES2384094T3 (es)	1997-11-14	2012-06-29	Pacira Pharmaceuticals, Inc.	Producción de liposomas multivesiculares
CA2308495C (en) *	1997-11-19	2009-01-06	Darwin Discovery Limited	Anaesthetic formulation
ATE428371T1 (de)	1998-07-17	2009-05-15	Pacira Pharmaceuticals Inc	Biologisch abbaubare anordnungen zur kontrollierten freigabe eingeschlossener substanzen
BR0002246A (pt)	2000-04-06	2003-04-15	Cristalia Prod Quimicos Farm	Processo de obtenção dos enantiÈmeros da bupivacaìna racêmica, processo de obtenção de composições farmacêuticas a base de levobupivacaìna: composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis e utilização das composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis
NZ529544A (en) *	2001-05-31	2006-11-30	Skyepharma Inc	Encapsulation of nanosuspensions in liposomes and microspheres
US7829109B2 (en)	2001-11-14	2010-11-09	Durect Corporation	Catheter injectable depot compositions and uses thereof
US20040001889A1 (en)	2002-06-25	2004-01-01	Guohua Chen	Short duration depot formulations
JP2006503004A (ja)	2002-07-31	2006-01-26	アルザ・コーポレーション	射出可能なデポ組成物及びその使用
DK1539101T3 (da)	2002-07-31	2009-04-27	Alza Corp	Injicerbare, multi-modale polymere depotsammens tninger og anvendelser deraf
EP2484347A1 (en)	2006-11-03	2012-08-08	Durect Corporation	Transdermal delivery systems comprising bupivacaine
DE102008037682A1 (de) *	2008-08-14	2010-04-08	Strackharn, Klaus, Dr.med.	Verwendung äquipotenter Dosierungen von Lokalanästetika oder Derivaten davon zur Therapie chronischer Schmerzen
CA2931547A1 (en)	2013-12-09	2015-06-18	Durect Corporation	Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same
KR102442753B1 (ko) *	2016-12-26	2022-09-16	셀릭스 바이오 프라이빗 리미티드	만성 통증 치료를 위한 화합물
US11278494B1 (en)	2021-01-22	2022-03-22	Pacira Pharmaceuticals, Inc.	Manufacturing of bupivacaine multivesicular liposomes
US12151024B2 (en)	2021-01-22	2024-11-26	Pacira Pharmaceuticals, Inc.	Manufacturing of bupivacaine multivesicular liposomes
US11357727B1 (en)	2021-01-22	2022-06-14	Pacira Pharmaceuticals, Inc.	Manufacturing of bupivacaine multivesicular liposomes
US11033495B1 (en)	2021-01-22	2021-06-15	Pacira Pharmaceuticals, Inc.	Manufacturing of bupivacaine multivesicular liposomes
WO2023064464A1 (en)	2021-10-14	2023-04-20	Pacira Pharmaceuticals, Inc.	Bupivacaine multivesicular liposome formulations and uses thereof
US12070454B1 (en)	2022-05-05	2024-08-27	Pfof Llc	Anesthetic nerve block and method
CN119677554A (zh)	2022-05-05	2025-03-21	普络夫有限责任公司	麻醉神经阻滞和方法
US12251472B1 (en)	2024-05-20	2025-03-18	Pacira Pharmaceuticals, Inc.	Manufacturing of bupivacaine multivesicular liposomes
US12280149B1 (en)	2024-05-20	2025-04-22	Pacira Pharmaceuticals, Inc.	Manufacturing of bupivacaine multivesicular liposomes
US12156940B1 (en)	2024-05-20	2024-12-03	Pacira Pharmaceuticals, Inc.	Manufacturing of bupivacaine multivesicular liposomes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4695576A (en) *	1984-07-09	1987-09-22	Astra Lake Medel Aktiebolag	L-N-n-propylpipecolic acid-2,6-xylidide
ES2170179T3 (es) *	1993-10-13	2002-08-01	Darwin Discovery Ltd	Agente analgesico y su utilizacion.
ITTO20010597A1 (it) *	2001-06-20	2002-12-20	Plaset Spa	Pompa per liquidi, in particolare pompa centrifuga per apparecchi elettrodomestici.

1993
- 1993-10-13 GB GB939321061A patent/GB9321061D0/en active Pending
1994
- 1994-10-13 US US08/628,689 patent/US5955479A/en not_active Expired - Lifetime
- 1994-10-13 DK DK94929595.0T patent/DK0723444T3/da active
- 1994-10-13 HK HK98105742A patent/HK1006421A1/en not_active IP Right Cessation
- 1994-10-13 WO PCT/GB1994/002248 patent/WO1995010276A1/en not_active Ceased
- 1994-10-13 ES ES94929595T patent/ES2105766T3/es not_active Expired - Lifetime
- 1994-10-13 AU AU78593/94A patent/AU692477B2/en not_active Expired
- 1994-10-13 JP JP7511488A patent/JPH09503777A/ja active Pending
- 1994-10-13 CA CA002173208A patent/CA2173208C/en not_active Expired - Lifetime
- 1994-10-13 KR KR1019960701863A patent/KR100343314B1/ko not_active Expired - Lifetime
- 1994-10-13 AT AT94929595T patent/ATE154758T1/de active
- 1994-10-13 EP EP94929595A patent/EP0723444B1/en not_active Expired - Lifetime
- 1994-10-13 DE DE69403969T patent/DE69403969T2/de not_active Expired - Lifetime
- 1994-10-13 CN CN94193775A patent/CN1074919C/zh not_active Expired - Lifetime
1996
- 1996-04-12 NO NO961478A patent/NO309304B1/no not_active IP Right Cessation
1997
- 1997-09-17 GR GR970402411T patent/GR3024787T3/el unknown

Also Published As

Publication number	Publication date
CN1133009A (zh)	1996-10-09
JPH09503777A (ja)	1997-04-15
KR100343314B1 (ko)	2003-02-19
DE69403969T2 (de)	1997-11-20
AU692477B2 (en)	1998-06-11
CA2173208A1 (en)	1995-04-20
DE69403969D1 (de)	1997-07-31
CA2173208C (en)	2007-01-30
AU7859394A (en)	1995-05-04
NO961478D0 (no)	1996-04-12
ATE154758T1 (de)	1997-07-15
NO961478L (no)	1996-06-11
CN1074919C (zh)	2001-11-21
US5955479A (en)	1999-09-21
EP0723444B1 (en)	1997-06-25
ES2105766T3 (es)	1997-10-16
NO309304B1 (no)	2001-01-15
WO1995010276A1 (en)	1995-04-20
EP0723444A1 (en)	1996-07-31
GR3024787T3 (en)	1998-01-30
HK1006421A1 (en)	1999-02-26
GB9321061D0 (en)	1993-12-01

Publication	Publication Date	Title
DK0723444T3 (da)	1997-12-29	Levobupivacain, som er egnet til behandling af kronisk smerte
GEP20094798B (en)	2009-10-26	(s,s)-reboxetine for treating chronic pain
DE69805973D1 (de)	2002-07-18	Behandlung von herzrythmusstörungen durch hemmung einer multifunktionalen calcium/calmodulin-abhängigen protein kinase
DE69616376D1 (de)	2001-11-29	Verwendung von Tiagabin zur Behandlung von Schlafstörungen
DK0751778T3 (da)	2002-09-30	Anvendelse af deuteriumforarmet vand til fremstilling af hygiejniske og kosmetiske præparater
BR0213100A (pt)	2004-11-30	Combinações para o tratamento de distúrbios imuniinflamatórios
HUP0000873A2 (hu)	2000-09-28	A levobupivakain arcsebészeti alkalmazása
ATE214272T1 (de)	2002-03-15	Topische verwendung von kappa- opioidrezeptoragonisten zur behandlung von augenschmerz
DE59902666D1 (de)	2002-10-17	Edelfosin zur behandlung von hirntumoren
NO20005757D0 (no)	2000-11-14	Cabergolin og pramipexol - nye anvendelser og kombinasjoner
MXPA00010254A (es)	2002-08-06	Tratamiento de disfuncion sexual en ciertos grupos de pacientes.
ATE293972T1 (de)	2005-05-15	Behandlung von chronischen schmerzen
NO984189L (no)	1998-09-11	FremgangsmÕte for behandling av bipolar forstyrrelse
DE69627298D1 (de)	2003-05-15	Verwendung von sklareolide für die behandlung von excessiven zellwachstumskrankheiten
ATE302009T1 (de)	2005-09-15	Ubichinon qn zur behandlung von migräneschmerzen
NO984196D0 (no)	1998-09-11	Fremgangsmåte for behandling av stoffmisbruk
SE9101341D0 (sv)	1991-05-03	New medicinal use
DE3585312D1 (de)	1992-03-12	Anwendung von 1,6-dimethyl-4-oxo-1,6,7,8,9a-hexahydro-4h-pyrido(1,2-a)pyrimidin-3-carboxamid zur vorbeugung und behandlung von gastrointestinalschaeden.
ATE150645T1 (de)	1997-04-15	Verwendung von bmy 14802 zur behandlung von angstzuständen bei patienten mit benzodiazepin- entzugserscheinungen
DE69635282D1 (de)	2006-02-23	Behandlung der exzessiven aggressivität mit olanzapine
ATE288263T1 (de)	2005-02-15	Verwendung von n-oleoylethanolamin zur behandlung der schuppenflechte (psoriasis)
NO984190L (no)	1998-09-11	FremgangsmÕte for behandling av insomnia
RU93048255A (ru)	1996-11-10	Способ лечения вибрационной болезни
MX9704887A (es)	1998-06-30	Composiciones farmaceuticas para el tratamiento de trastornos depresivos.
UA22223A (uk)	1998-06-30	Спосіб лікуваhhя захворюваhь оргаhа зору